Psychotropic medication use: what will it do to my liver?

Area of Science:

• Pharmacology
• Hepatology
• Toxicology

Background:

• Drug-induced liver injury (DILI) is a primary cause for drug withdrawal and development termination.
• Psychotropic medications, including anticonvulsants, antidepressants, and antipsychotics, can cause liver injury, though severe cases are rare.
• Mild, asymptomatic elevations in liver function tests (LFTs) are common but do not predict severe outcomes.

Purpose of the Study:

• To evaluate the significance of liver toxicity in drug development.
• To assess the utility of laboratory monitoring versus clinical monitoring for psychotropic drug-induced liver injury.

Main Methods:

• Review of literature on drug-induced liver injury associated with psychotropic medications.
• Analysis of the predictive value of LFTs for severe liver injury.
• Comparison of laboratory monitoring versus clinical monitoring strategies.

Main Results:

• While severe liver injury from psychotropic drugs is uncommon, mild LFT elevations are frequent and not indicative of progression.
• Laboratory monitoring is recommended for valproic acid and carbamazepine but not generally for other psychotropic drugs.
• Regular laboratory testing is unreliable for detecting or preventing severe liver injury.

Conclusions:

• Clinical monitoring for signs and symptoms of hepatotoxicity and hypersensitivity reactions is paramount.
• Emphasis should shift from routine laboratory testing to vigilant clinical observation for managing potential liver injury from psychotropic drugs.